Mariner
YARW

Mariner’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Mariner’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14
Closed -$2K – 2886
2022
Q4 		$2K Sell
14
-2
-13% -$400 ﹤0.01% 2734
2022
Q3 		$3K Buy
+16
New +$5.12K ﹤0.01% 2436

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Mariner's YARW Position: Q1 2023 in Review

Mariner sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2023, closing a stake of 14 shares — an estimated $2K sold.

Mariner first reported a position in YARW in Q3 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2022. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Mariner reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Mariner sold 14 Yarrow Bioscience, Inc. Common Stock shares in Q1 2023, an estimated $2K.
  • Mariner first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Mariner's Yarrow Bioscience, Inc. Common Stock position peaked at $3K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on Mariner's 13F filing for Q1 2023, filed 15 May 2023.